Ireland - English - HPRA (Health Products Regulatory Authority)

imed healthcare ltd. - pancreatin - gastro-resistant capsule, hard - 300 milligram(s) - enzyme preparations; multienzymes (lipase, protease etc.)

Ireland - English - HPRA (Health Products Regulatory Authority)

ltt pharma limited - pancreatin - gastro-resistant capsule - 10000 units/dose - enzyme preparations; multienzymes (lipase, protease etc.)

Ireland - English - HPRA (Health Products Regulatory Authority)

ltt pharma limited - pancreatin - gastro-resistant capsule - 25000 units/dose - enzyme preparations; multienzymes (lipase, protease etc.)

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - pancreatin 60.12mg (3,600 ph. eur. u/amylase, 5,000 ph. eur. u/lipase and 200 ph. eur. u/protease) - modified release granules - 60.12 mg - active: pancreatin 60.12mg (3,600 ph. eur. u/amylase, 5,000 ph. eur. u/lipase and 200 ph. eur. u/protease) excipient: cetyl alcohol dimeticone hypromellose phthalate macrogol 4000 triethyl citrate - for treatment of conditions associated with pancreatic exocrine insufficiency, such as: cystic fibrosis, chronic pancreatitis, post-pancreatectomy, post-gastrointestinal bypass surgery, e.g. billroth ii, gastroenterostomy; ductal obstruction of the pancreas or common bile duct (e.g. from neoplasm).

Ireland - English - HPRA (Health Products Regulatory Authority)

imbat limited - pancreatin - gastro-resistant capsule - 25000 - enzyme preparations

Ireland - English - HPRA (Health Products Regulatory Authority)

imed healthcare ltd. - pancreatin - gastro-resistant capsule - 150 milligram(s) - enzyme preparations; multienzymes (lipase, protease etc.)

Ireland - English - HPRA (Health Products Regulatory Authority)

b & s healthcare - pancreatin - capsule - 150 milligram - enzyme preparations

Canada - English - Health Canada

enzymatic therapy (canada) inc. - pancreatin (protease, amylase, lipase); papain; bromelain; chymotrypsin - tablet - 1625mg; 25mg; 25mg; 1mg - pancreatin (protease, amylase, lipase) 1625mg; papain 25mg; bromelain 25mg; chymotrypsin 1mg - digestants

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - pancreatin 314.65mg - 350.175mg ((25000u lipase, 22500u amylase, 1250u protease)) - modified release capsule - active: pancreatin 314.65mg - 350.175mg ((25000u lipase, 22500u amylase, 1250u protease)) excipient: colloidal silicon dioxide crospovidone gelatin   glycol montanate iron oxide black iron oxide red magnesium stearate methacrylic acid - ethyl acrylate copolymer microcrystalline cellulose purified talc simeticone titanium dioxide triethyl citrate erythrosine gelatin   patent blue v - panzytrat is indicated for patients with exocrine pancreatic enzyme deficiency such as (but not restricted to): · cystic fibrosis · chronic pancreatitis · post-pancreatectomy · post-gastrointestinal bypass surgery e.g. billroth ii gastroenterostomy · ductal obstructions from neoplasm e.g. of the pancreas or common bile duct

Malta - English - Medicines Authority

abbott healthcare products limited - pancreatin 300 mg - capsule